Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Evening Primrose Oil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase II
Sponsor : Zhengzhou Children’s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | Göteborg University
Deal Size : Inapplicable
Deal Type : Inapplicable
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
April 18, 2019
Lead Product(s) : Evening Primrose Oil
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Sponsor : Zhengzhou Children’s Hospital | The First Affiliated Hospital of Zhengzhou University | Women and Children Health Care Center of Luoyang, China | Göteborg University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Evening Primrose Oil
Therapeutic Area : Hematology
Study Phase : Phase I/ Phase II
Sponsor : AMAG Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
July 15, 2014
Lead Product(s) : Evening Primrose Oil
Therapeutic Area : Hematology
Highest Development Status : Phase I/ Phase II
Sponsor : AMAG Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable